ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
4D Molecular Therapeutics Inc

4D Molecular Therapeutics Inc (FDMT)

3.92
0.17
(4.53%)
Closed March 22 4:00PM
3.95
0.03
(0.77%)
After Hours: 7:44PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.25M298k240k20.2M-19k28k5k3k
Operating Income -28.72M-30.11M-32.14M-13.97M-36.65M-38.14M-42.46M-51.13M
Pre Tax Income -27.38M-28.68M-29.62M-10.26M-32.28M-32.4M-34.95M-43.84M
Net Income -27.38M-28.68M-29.62M-10.26M-32.28M-32.4M-34.95M-43.84M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -28.72M-30.13M-32.13M-14.13M-36.66M-38.15M-42.51M-51.15M
EBITDA -27.71M-29.08M-31.06M-12.98M-35.55M-36.96M-41.26M-49.94M
Year End December 30 2023 201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 14.13M6.99M13.61M18.04M3.13M20.72M
Operating Income -10.4M-50.76M-56.66M-71.33M-110.03M-112.87M
Pre Tax Income -9.55M-49.31M-56.69M-71.32M-107.49M-100.84M
Net Income -9.55M-49.31M-56.69M-71.32M-107.49M-100.84M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -1.863-9.52-2.125-2.213-3.295-2.359
EBIT -10.4M-50.81M-56.85M-71.45M-110.07M-113.05M
EBITDA -9.7M-49.76M-55.22M-69.81M-107.63M-108.66M